# US 2001/0024822 A1 · Method for inducing immunosuppressive cells and a culture device to be used therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024822 A1
- Document ID: US20010024822A1
- Status: Published application
- Kind: A1
- Application number: 09/756,214
- Filed: 2001-01-09
- Published: 2001-09-27
- Earliest claimed: 1996-09-03
- Inventors: Kenji Yamashita; Takeshi Fukuchi; Tomoko Nishino
- Web page: https://patentgrep.com/patent/US20010024822A1

## CPC

- C12N 5/0636: {T lymphocytes}
- C12M 25/00: {Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings}
- A61K 2035/122: {for inducing tolerance or supression of immune responses}
- C12N 2501/23: Interleukins [IL]
- C12N 2501/515: CD3, T-cell receptor complex
- C12N 2501/599: with CD designations not provided for elsewhere
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a method for inducing immunosuppressive cells by cultivating human cells with the use of a culture device having an affinity for protein and the culture device to be used therefor. According to the present invention, immunosuppressive cells can be efficiently induced by using a solid culture and can provide an efficient therapeutic system for diseases caused by hypersensitivity of the immune system with less side effect.

## Claims

### Claim 1

A method for inducing immunosuppressive cells, which comprises culturing human cells with the use of a culture device having an affinity for protein.

### Claim 2 (depends on 1)

The inducing method of claim 1, wherein the culture device is previously coated with one or more cytokines or antibodies against surface antigens.

### Claim 3 (depends on 1)

The inducing method of claim 1, wherein the culture device is previously coated with two or more antibodies against surface antigens, each of said antibodies recognizing different epitope.

### Claim 4 (depends on 1)

The inducing method of claim 1, wherein human cells and one or more cytokines or antibodies against surface antigens are mixed.

### Claim 5 (depends on 1)

The inducing method of claim 1, wherein human cells and two or more antibodies against surface antigens, each of said antibodies recognizing different epitope, are mixed.

### Claim 6 (depends on 2, 3, 4, 5)

The inducing method of claim 2, 3, 4 or 5, wherein the antibody against surface antigens is an anti-CD2 antibody or an anti-CD3 antibody.

### Claim 7 (depends on 2, 3, 4, 5, 6)

The inducing method of claim 2, 3, 4, 5 or 6, wherein the antibody against surface antigens is an anti-CD2 antibody, said anti-CD2 antibody binding to a site of CD2 that participates in the binding of LFA-3 to CD2.

### Claim 8 (depends on 2, 3, 4, 5, 6)

The inducing method of claim 2, 3, 4, 5 or 6, wherein the antibody against surface antigens is an anti-CD2 antibody, said anti-CD2 antibody binding to a site of CD2 other than a site of CD2 which participates in the binding of LFA-3 to CD2.

### Claim 9 (depends on 3, 5)

The inducing method of claim 3 or 5, wherein two or more antibodies against surface antigens are anti-CD2 antibodies comprising a combination of one or more antibodies which bind to a site of CD2 that participates in the binding of LFA-3 to CD2 and one or more antibodies which bind to a site of CD2 other than the site of CD2 which participates in the binding of LFA-3 to CD2.

### Claim 10 (depends on 2, 3, 4, 5, 6, 7, 8)

The inducing method of claim 2, 3, 4, 5, 6, 7 or 8, wherein one antibody against surface antigens is the anti-CD2 antibody TS2/18.

### Claim 11 (depends on 2, 3, 4, 5, 6, 7, 8)

The inducing method of claim 2, 3, 4, 5, 6, 7 or 8, wherein one antibody against surface antigens is the F(ab)2 fragment of the anti-CD2 antibody TS2/18.

### Claim 12 (depends on 2, 4)

The inducing method of claim 2 or 4, wherein the cytokine is IL-2 or GM-CSF.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, wherein 0.5 to 10% by volume of serum based on a culture medium is mixed in the culture.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, wherein no serum is mixed with the culture medium in the culture.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14, wherein a term of the culture ranges between 1 and 7 days.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15, wherein the culture device is made of material having an affinity for protein.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16, wherein the culture device is made of plastic material.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16, wherein the culture device is made of glass material.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The inducing method of claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 or 18, wherein the culture device is a closed plane plate vessel or a closed vessel charged with spherical fine-particles.

### Claim 20

A culture device having an affinity for protein, which is used for inducing immunosuppressive cells by culturing human cells.

### Claim 21 (depends on 20)

The culture device of claim 20, wherein the device is previously coated with one or more cytokines or antibodies against surface antigens.

### Claim 22 (depends on 20)

The culture device of claim 20, wherein the device is previously coated with two or more antibodies against surface antigens, each of said antibodies recognizing different epitope.

### Claim 23 (depends on 21, 22)

The culture device of claim 21 or 22, wherein the antibody against surface antigens is anti-CD2 antibody or anti-CD3 antibody.

### Claim 24 (depends on 22, 23)

The culture device of claim 22 or 23, wherein one or more antibodies that recognize different epitope are the anti-CD2 antibody TS2/18.
